Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral zinc sulfate for prevention of radiotherapy-induced acute dermatitis in breast cancer
IRCT20200621047857N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in radiodermatitis and breast cancer, sponsored by Kerman University of Medical Sciences. Primary endpoint: Incidence and severity of acute radiotherapy-induced dermatitis. Started May 2021; status: completed.
02
Drugs
zinc
03
Conditions
radiodermatitisbreast cancer
Beyond the preview
Go deeper on IRCT20200621047857N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200621047857N1.